Main Street Research’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,250
Closed -$223K 110
2019
Q3
$223K Hold
2,250
0.04% 92
2019
Q2
$208K Hold
2,250
0.05% 90
2019
Q1
$212K Buy
+2,250
New +$197K 0.07% 83
2018
Q4
Sell
-2,585
Closed -$231K 115
2018
Q3
$231K Hold
2,585
0.03% 99
2018
Q2
$205K Hold
2,585
0.03% 111
2018
Q1
$231K Sell
2,585
-8,708
-77% -$836K 0.04% 101
2017
Q4
$1.18M Sell
11,293
-2,185
-16% -$247K 0.18% 54
2017
Q3
$1.97M Sell
13,478
-550
-4% -$74.9K 0.32% 50
2017
Q2
$1.82M Buy
14,028
+1,780
+15% +$218K 0.3% 55
2017
Q1
$1.52M Sell
12,248
-150
-1% -$18K 0.27% 60
2016
Q4
$1.44M Sell
12,398
-650
-5% -$72.4K 0.28% 59
2016
Q3
$1.36M Sell
13,048
-700
-5% -$75.8K 0.27% 62
2016
Q2
$1.36M Buy
13,748
+200
+1% +$20.7K 0.28% 60
2016
Q1
$1.36M Buy
13,548
+1,074
+9% +$111K 0.35% 52
2015
Q4
$1.49M Sell
12,474
-420
-3% -$48.6K 0.32% 66
2015
Q3
$1.58M Sell
12,894
-1,531
-11% -$190K 0.37% 64
2015
Q2
$1.67M Buy
14,425
+341
+2% +$39K 0.34% 75
2015
Q1
$1.62M Buy
14,084
+280
+2% +$33.5K 0.35% 74
2014
Q4
$1.54M Hold
13,804
0.33% 75
2014
Q3
$1.31M Hold
13,804
0.29% 82
2014
Q2
$1.19M Buy
13,804
+100
+0.7% +$7.61K 0.28% 80
2014
Q1
$957K Sell
13,704
-100
-0.7% -$7.92K 0.23% 85
2013
Q4
$1.17M Buy
13,804
+666
+5% +$52.7K 0.29% 82
2013
Q3
$1.01M Sell
13,138
-1,750
-12% -$123K 0.27% 82
2013
Q2
$871K Buy
+14,888
New +$896K 0.26% 86

Other funds holding CELG

Main Street Research's CELG Position: Q4 2019 in Review

Main Street Research sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,250 shares — an estimated $223K sold.

Main Street Research first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $1.97M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Main Street Research reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Main Street Research sold 2,250 Celgene Corp shares in Q4 2019, an estimated $223K.
  • Main Street Research first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • Main Street Research's Celgene Corp position peaked at $1.97M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Main Street Research's 13F filing for Q4 2019, filed 28 Jan 2020.